Compare TECX & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TECX | BOW |
|---|---|---|
| Founded | 2019 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Property-Casualty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.9M | 734.3M |
| IPO Year | 2018 | 2024 |
| Metric | TECX | BOW |
|---|---|---|
| Price | $19.69 | $34.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $71.00 | $34.33 |
| AVG Volume (30 Days) | 182.1K | ★ 205.1K |
| Earning Date | 11-13-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.70 | 23.26 |
| EPS | N/A | ★ 0.96 |
| Revenue | N/A | ★ $551,589,000.00 |
| Revenue This Year | N/A | $23.79 |
| Revenue Next Year | N/A | $20.28 |
| P/E Ratio | ★ N/A | $35.66 |
| Revenue Growth | N/A | ★ 29.58 |
| 52 Week Low | $15.60 | $21.21 |
| 52 Week High | $39.53 | $35.07 |
| Indicator | TECX | BOW |
|---|---|---|
| Relative Strength Index (RSI) | 30.40 | 59.94 |
| Support Level | $16.77 | $33.66 |
| Resistance Level | $22.44 | $34.38 |
| Average True Range (ATR) | 1.08 | 0.19 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 4.51 | 31.88 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.